Concepedia

Joerg Rinnenthal

JR

6

Publications

1K

Citations

6

H-Index

2018

Active since

Affiliations

Boehringer Ingelheim (Austria)(Current)

University of Dundee

Boehringer Ingelheim (Germany)

Joerg Rinnenthal is an author at Boehringer Ingelheim (Austria) specializing in tumor biology, cancer research, and medicine.

Top concepts

MedicineTumor BiologyCancer ResearchOncologyImmunologyProteomicsPharmacologyCancer BiologyCancer TherapyDrug Discovery

Publications per year

2018–2022

6

Publications

6

BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design

William Farnaby, Manfred Koegl, Michael J. Roy et al. · Nature Chemical Biology · 2019 · 553 citations · Full text

Tumor Biology, Medicine, Natural Sciences +10

A selective and orally bioavailable VHL-recruiting PROTAC achieves SMARCA2 degradation in vivo

Christiane Kofink, Nicole Trainor, Barbara Mair et al. · Nature Communications · 2022 · 194 citations · Full text

Highly Selective PTK2 Proteolysis Targeting Chimeras to Probe Focal Adhesion Kinase Scaffolding Functions

Johannes Popow, Heribert Arnhof, Gerd Bader et al. · Journal of Medicinal Chemistry · 2019 · 137 citations · Full text

Intracellular Trapping of the Selective Phosphoglycerate Dehydrogenase (PHGDH) Inhibitor <b>BI-4924</b> Disrupts Serine Biosynthesis

Harald Weinstabl, Matthias Treu, Joerg Rinnenthal et al. · Journal of Medicinal Chemistry · 2019 · 80 citations · Full text

Selective Tumor Cell Apoptosis and Tumor Regression in CDH17-Positive Colorectal Cancer Models using BI 905711, a Novel Liver-Sparing TRAILR2 Agonist

Juan Manuel García‐Martínez, Shirley Wang, Cordula Weishaeupl et al. · Molecular Cancer Therapeutics · 2020 · 39 citations · Full text

Rows per page

1–5 of 6